* Agreement covers intellectual property relating to biopharmaceutical manufacturing technologies
Aubagne, France; Goettingen, Germany and Chalfont St. Giles, UK - September 12, 2011 -- Sartorius Stedim Biotech has entered into a patent cross-licensing agreement with GE Healthcare Life Sciences. This will enable the further development of each company's current and future biopharmaceutical manufacturing technologies.
business unit
tags
Adopted by more than 100 leading clinicians worldwide, Alcyone technology has become an accepted technology for nuclear cardiology diagnosis
Harnessing four advanced nuclear imaging innovations, Alcyone technology has the ability to reduce scan time and/or injected dose while maintaining image quality †
business unit
tags
* Deal Strengthens GE's Position in $30 Billion Power Conversion and Automation Sector
* Converteam Technological Expertise to Enhance GE's Ability to Bring Localized Solutions to Fast Growth Regions
* Broadens GE Offerings for Energy Intensive Industries Such as Mining, Metals and Marine
business unit
tags
GE's PET/CT +MR technology may hold promise in management of cancer, neurodegenerative and cardiac diseases
WAUKESHA, WI August 30, 2011---Hong Kong Sanatorium & Hospital (HKSH) has selected GE Healthcare's tri-modality imaging solution---PET/CT+MR---which may potentially enhance the ability of physicians to manage certain diseases.
business unit
tags
- 16 Units Selected for LNG Refrigeration Trains
- GE Oil & Gas' First Installation of an LM6000 Mechanical Drive Turbine
FLORENCE, ITALY---July 26, 2011---GE Oil & Gas has entered into an agreement with Bechtel International, Inc. for the supply of compression technology for two customized LNG refrigeration trains for the Chevron-operated Wheatstone Project in Western Australia. A final investment decision on the Wheatstone Project is expected in the second half of 2011.